Trial Profile
Investigation of 6-week versus 6-month clopidogrel therapy in patients with concomitant aspirin and oral anticoagulants therapy after implantation of a drug-eluting stent [Undersogelse af 6-uger versus 6-maneders clopidogrel behandling hos patienter med samtidig aspirin og oral angikoagulans behandling efter implantation af en drug-eluting stent].
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Dec 2014
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary)
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Therapeutic Use
- 13 Dec 2014 Status changed from recruiting to completed as reported by European Clinical Trials Database.